Condition: Cutaneous Melanoma · Mucosal Melanoma · Sponsor: Mural Oncology, Inc
This study observes the antitumor activity, safety, tolerability, PK, and pharmacodynamics in patients with inoperable and/or metastatic melanoma
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| UC San Diego Moores Cancer Center | La Jolla, California, United States | — |
| The Angeles Clinic and Research Institute | Los Angeles, California, United States | — |
| Mayo Clinic | Jacksonville, Florida, United States | — |
| Orlando Health, Inc | Orlando, Florida, United States | — |
| Norton Cancer Center | Louisville, Kentucky, United States | — |
| Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| NYU Laura and Isaac Perimutter Cancer Center | New York, New York, United States | — |
| Columbia University Medical Center | New York, New York, United States | — |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | — |
| UT Southwestern Medical Center of Dallas | Dallas, Texas, United States | — |
| Calvary Mater Newcastle | Waratah, New South Wales, Australia | — |
| John Flynn Private Hospital | Tugun, Queensland, Australia | — |
+ 29 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04830124